API | o-chlorophentermine

o-chlorophentermine Report issue

Small molecule Experimental

ChEMBL DrugBank Drug Central KEGG PubChem

Active Ingredient History

Clortermine hydrochloride (Voranil) is a non-amphetamine anorexigenic agent. Voranil, a sympathomimetic amine, is indicated for short-term adjunctive treatment of exogenous obesity. Its long duration of action permits once-a-day dosage. In a large number of patients studied, Voranil was found to be superior to placebo in weight reduction. Insomnia, dry mouth, palpitations and tachycardia have been reported in a small percentage of patients taking the drug. Voranil was originally developed by Ciba Pharmaceuticals Corporation and transferred to USV Pharmaceuticals Corporation in December 1971, as a result of a product exchange agreement. ^NCATS

Chemistry

SMILES: CC(C)(N)Cc1ccccc1Cl
InChIKey: HXCXASJHZQXCKK-UHFFFAOYSA-N
Mol. Mass: 183.68
ALogP: 2.62 Partition coefficient
ChEMBL Molecules:

clortermine

clortermine hydrochloride

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

chlortermine | clortermine | clortermine hcl | clortermine hydrochloride | o-chlorophentermine

Indications (1)

Approved Indications (1)

Obesity

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue